| Literature DB >> 22619602 |
Grażyna Zydek1, Elżbieta Brzezińska.
Abstract
A quantitative structure-activity relationship (QSAR) study has been made on 20 compounds with serotonin (5-HT) receptor affinity. Thin-layer chromatographic (TLC) data and physicochemical parameters were applied in this study. RP2 TLC 60F(254) plates (silanized) impregnated with solutions of propionic acid, ethylbenzene, 4-ethylphenol, and propionamide (used as analogues of the key receptor amino acids) and their mixtures (denoted as S1-S7 biochromatographic models) were used in two developing phases as a model of drug-5-HT receptor interaction. The semiempirical method AM1 (HyperChem v. 7.0 program) and ACD/Labs v. 8.0 program were employed to calculate a set of physicochemical parameters for the investigated compounds. Correlation and multiple linear regression analysis were used to search for the best QSAR equations. The correlations obtained for the compounds studied represent their interactions with the proposed biochromatographic models. The good multivariate relationships (R(2) = 0.78-0.84) obtained by means of regression analysis can be used for predicting the quantitative effect of biological activity of different compounds with 5-HT receptor affinity. "Leave-one-out" (LOO) and "leave-N-out" (LNO) cross-validation methods were used to judge the predictive power of final regression equations.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22619602 PMCID: PMC3349105 DOI: 10.1100/2012/157950
Source DB: PubMed Journal: ScientificWorldJournal ISSN: 1537-744X
Known biological activity for compounds 1–20.
| No. | Compound | p | p | p |
|---|---|---|---|---|
| 1 | Tiapride | — | 7.97 | 5.10 |
| 2 | Clopenthixol | 7.60 | 7.99 | 7.30 |
| 3 | Flupentixol | 7.00 | 7.88 | 6.90 |
| 4 | Trifluoperazine | 7.90 | 8.04 | 5.70 |
| 5 | Clozapine | 6.00 | — | 7.50 |
| 6 | Risperidone | 9.90 | 8.16 | 6.69 |
| 7 | Olanzapine | 8.10 | 8.10 | 7.20 |
| 8 | Tropisetron | 8.40 | — | 6.60 |
| 9 | Cyproheptadine | 8.22 | — | 8.73 |
| 10 | Trazodone | 7.40 | — | 8.79 |
| 11 | Mianserin | 9.70 | 8.09 | 7.50 |
| 12 | Pizotifen | 7.40 | — | 9.20 |
| 13 | Mirtazapine | 8.40 | 6.88 | 7.99 |
| 14 | Buspirone | 7.70 | 7.70 | 6.35 |
| 15 | Sumatriptan | 6.60 | 5.80 | — |
| 16 | Rizatriptan | 6.40 | 6.30 | — |
| 17 | Zolmitriptan | 6.60 | 6.20 | — |
| 18 | Cisapride | 7.40 | 7.60 | 7.30 |
| 19 | Serotonin | 6.40 | — | — |
| 20 | Propranolol | 7.50 | — | 6.08 |
apK i: 5-HT receptor binding affinity; bpD 2: agonistic activity; cpA 2: antagonistic activity.
R values for the experiment with RP2 TLC system.
| RP2 TLC | ||||||||
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| Compound |
|
|
|
|
|
|
|
|
|
| ||||||||
| Developing solvent | ||||||||
| 1 | −0.140 | −0.167 | −0.131 | −0.176 | −0.185 | −0.176 | −0.105 | −0.140 |
| 2 | 0.026 | 0.026 | 0.140 | 0.043 | 0.078 | 0.087 | 0.105 | 0.087 |
| 3 | 0.043 | 0.043 | 0.131 | 0.043 | 0.087 | 0.078 | 0.096 | 0.096 |
| 4 | 0.308 | 0.308 | 0.389 | 0.298 | 0.317 | 0.308 | 0.368 | 0.327 |
| 5 | −0.026 | −0.035 | 0.035 | 0.000 | 0.009 | −0.009 | 0.035 | 0.009 |
| 6 | −0.259 | −0.269 | −0.231 | −0.317 | −0.269 | −0.368 | −0.250 | −0.240 |
| 7 | 0.078 | 0.087 | 0.176 | 0.078 | 0.096 | 0.096 | 0.149 | 0.140 |
| 8 | 0.122 | 0.105 | 0.149 | 0.061 | 0.061 | 0.000 | 0.131 | 0.105 |
| 9 | 0.269 | 0.259 | 0.288 | 0.222 | 0.240 | 0.231 | 0.278 | 0.259 |
| 10 | −0.466 | −0.466 | −0.410 | −0.410 | −0.389 | −0.421 | −0.389 | −0.368 |
| 11 | −0.035 | −0.035 | 0.000 | −0.035 | −0.026 | −0.009 | 0.000 | 0.017 |
| 12 | 0.269 | 0.278 | 0.308 | 0.250 | 0.231 | 0.222 | 0.288 | 0.327 |
| 13 | −0.122 | −0.122 | −0.061 | −0.122 | −0.122 | −0.087 | −0.070 | −0.070 |
| 14 | −0.337 | −0.337 | −0.231 | −0.337 | −0.317 | −0.317 | −0.269 | −0.269 |
| 15 | −0.078 | −0.140 | −0.070 | −0.176 | −0.222 | −0.158 | −0.122 | −0.140 |
| 16 | 0.194 | 0.203 | 0.399 | 0.213 | 0.140 | 0.259 | 0.240 | 0.231 |
| 17 | −0.078 | −0.096 | 0.017 | −0.114 | −0.167 | −0.070 | −0.035 | −0.105 |
| 18 | −0.240 | −0.231 | −0.105 | −0.213 | −0.222 | −0.213 | −0.185 | −0.185 |
| 19 | 0.087 | 0.087 | 0.194 | 0.035 | 0.017 | −0.026 | 0.140 | 0.087 |
| 20 | 0.105 | 0.105 | 0.176 | 0.078 | 0.043 | 0.026 | 0.114 | 0.096 |
|
| ||||||||
| Developing solvent | ||||||||
|
| ||||||||
| 1 | 0.009 | 0.009 | 0.035 | −0.035 | −0.026 | 0.026 | 0.026 | 0.009 |
| 2 | 0.269 | 0.259 | 0.259 | 0.213 | 0.222 | 0.278 | 0.250 | 0.222 |
| 3 | 0.250 | 0.259 | 0.240 | 0.194 | 0.213 | 0.278 | 0.231 | 0.185 |
| 4 | 0.513 | 0.489 | 0.477 | 0.454 | 0.466 | 0.501 | 0.466 | 0.432 |
| 5 | 0.194 | 0.194 | 0.149 | 0.122 | 0.140 | 0.203 | 0.149 | 0.105 |
| 6 | 0.070 | 0.052 | 0.043 | 0.000 | 0.035 | 0.061 | 0.026 | −0.017 |
| 7 | 0.327 | 0.368 | 0.347 | 0.259 | 0.288 | 0.288 | 0.308 | 0.259 |
| 8 | 0.131 | 0.096 | 0.131 | 0.070 | 0.114 | 0.087 | 0.131 | 0.096 |
| 9 | 0.410 | 0.378 | 0.389 | 0.317 | 0.358 | 0.410 | 0.368 | 0.347 |
| 10 | −0.250 | −0.250 | −0.308 | −0.389 | −0.317 | −0.231 | −0.288 | −0.368 |
| 11 | 0.203 | 0.194 | 0.185 | 0.122 | 0.158 | 0.122 | 0.158 | 0.105 |
| 12 | 0.489 | 0.432 | 0.149 | 0.368 | 0.347 | 0.466 | 0.389 | 0.378 |
| 13 | 0.149 | 0.149 | 0.131 | 0.078 | 0.096 | 0.158 | 0.114 | 0.078 |
| 14 | −0.009 | 0.026 | −0.043 | −0.140 | −0.087 | 0.009 | −0.017 | −0.017 |
| 15 | −0.009 | −0.035 | −0.017 | −0.070 | −0.070 | −0.026 | −0.026 | −0.078 |
| 16 | 0.278 | 0.308 | 0.317 | 0.240 | 0.231 | 0.298 | 0.278 | 0.240 |
| 17 | 0.017 | 0.000 | 0.043 | −0.035 | −0.026 | 0.035 | 0.026 | −0.026 |
| 18 | 0.122 | 0.140 | 0.105 | 0.035 | 0.061 | 0.131 | 0.096 | 0.061 |
| 19 | 0.203 | 0.222 | 0.231 | 0.149 | 0.140 | 0.176 | 0.194 | 0.149 |
| 20 | 0.203 | 0.222 | 0.185 | 0.114 | 0.131 | 0.176 | 0.203 | 0.158 |
a R M(C): retention parameter of the compounds in control environment of chromatography; b R M(S1−S7): retention parameters of the compounds in S1–S7 models environment of chromatography.
Calculated molecular descriptors for compounds 1–20.
| Compound |
|
| Δ |
|
|
|
|
|
| log |
|
|
|
| log | p | PSA | HD | HA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | −95473.52 | −4458.85 | −114.42 | 5.42 | −9.22 | −0.81 | 363.12 | 299.49 | −5.38 | −1.56 | 91.23 | 31.51 | 328.43 | −0.28 | −1.48 | 9.66 | 84.09 | 1 | 6 |
| 2 | −102871.32 | −5376.37 | 66.71 | 1.30 | −7.68 | −0.88 | 390.65 | 362.08 | −7.20 | −0.06 | 125.84 | 44.97 | 400.97 | −0.26 | 5.06 | 3.40 | 52.01 | 1 | 3 |
| 3 | −130832.64 | −5768.48 | −126.83 | 3.34 | −8.19 | −0.61 | 428.40 | 375.93 | −7.16 | 0.73 | 126.33 | 44.61 | 434.52 | −0.26 | 4.42 | 3.40 | 52.01 | 1 | 3 |
| 4 | −121985.47 | −5378.24 | −77.03 | 3.37 | −7.75 | −0.54 | 397.66 | 353.23 | −1.07 | −0.19 | 119.66 | 41.84 | 407.50 | −0.24 | 4.21 | 8.21 | 35.02 | 0 | 3 |
| 5 | −86841.85 | −4443.93 | 103.02 | 4.27 | −8.12 | −0.37 | 332.90 | 297.11 | −2.85 | −0.73 | 103.53 | 36.47 | 326.83 | −0.26 | 3.28 | 7.14 | 30.87 | 1 | 4 |
| 6 | −121479.92 | −5930.86 | −3.63 | 2.83 | −8.88 | −0.67 | 417.97 | 374.26 | −3.95 | 0.63 | 118.48 | 43.54 | 410.49 | −0.25 | 2.27 | 7.89 | 61.94 | 0 | 6 |
| 7 | −80076.44 | −4363.58 | 101.99 | 2.47 | −8.20 | −0.46 | 534.03 | 908.51 | −2.75 | −0.27 | 100.06 | 35.90 | 312.43 | −0.26 | 2.68 | 6.08 | 59.11 | 1 | 4 |
| 8 | −80841.49 | −4306.45 | −14.17 | 5.20 | −8.83 | −0.15 | 306.24 | 268.61 | −4.73 | −0.38 | 85.35 | 31.53 | 284.36 | −0.22 | 1.07 | 10.00 | 45.33 | 1 | 4 |
| 9 | −73412.66 | −4717.17 | 78.67 | 0.93 | −8.52 | −0.23 | 320.59 | 290.43 | −1.14 | 1.77 | 102.76 | 36.03 | 287.40 | −0.24 | 4.86 | 8.95 | 3.24 | 0 | 1 |
| 10 | −102872.02 | −4942.24 | 104.46 | 3.65 | −8.49 | −0.53 | 386.68 | 336.51 | −3.39 | 0.40 | 109.91 | 39.94 | 371.87 | −0.25 | 1.58 | 6.73 | 42.39 | 0 | 6 |
| 11 | −69008.06 | −4266.06 | 78.00 | 1.69 | −8.56 | 0.46 | 294.12 | 264.06 | −0.67 | 0.94 | 91.21 | 32.26 | 264.37 | −0.25 | 2.76 | 8.26 | 6.48 | 0 | 2 |
| 12 | −72005.62 | −4460.87 | 59.58 | 0.52 | −8.66 | 0.06 | 315.58 | 285.55 | −0.79 | 0.50 | 99.09 | 35.74 | 295.44 | −0.26 | 4.49 | 9.04 | 31.48 | 0 | 1 |
| 13 | −70511.88 | −4151.08 | 82.98 | 1.40 | −8.71 | 0.13 | 289.58 | 259.66 | −1.56 | 1.16 | 87.08 | 31.55 | 265.36 | −0.25 | 1.97 | 8.10 | 19.37 | 0 | 3 |
| 14 | −110495.96 | −5922.35 | −34.38 | 4.11 | −8.77 | 0.13 | 427.84 | 371.81 | −1.85 | 1.18 | 109.35 | 42.11 | 385.51 | −0.26 | 3.35 | 6.73 | 69.64 | 0 | 7 |
| 15 | −81555.82 | −4027.14 | −16.02 | 2.30 | −8.35 | −0.50 | 327.29 | 270.64 | −7.57 | −1.53 | 85.92 | 29.34 | 295.40 | −0.27 | −1.38 | 9.49 | 73.58 | 2 | 5 |
| 16 | −74102.91 | −3978.93 | 139.36 | 5.47 | −8.54 | 0.05 | 312.82 | 264.07 | −6.38 | −1.31 | 87.27 | 31.13 | 269.35 | −0.27 | −1.10 | 9.49 | 44.81 | 1 | 5 |
| 17 | −82988.15 | −4308.72 | −22.22 | 6.51 | −8.49 | 0.00 | 320.46 | 275.04 | −6.13 | −1.01 | 86.03 | 31.82 | 287.36 | −0.28 | −0.44 | 9.52 | 57.36 | 2 | 5 |
| 18 | −140797.97 | −6228.62 | −162.08 | 3.89 | −8.76 | −0.11 | 480.40 | 412.47 | −8.51 | 2.25 | 122.44 | 47.39 | 465.95 | −0.27 | 2.60 | 7.77 | 86.05 | 3 | 7 |
| 19 | −50258.52 | −2618.46 | 1.22 | 3.41 | −8.31 | 0.14 | 204.41 | 168.41 | −15.76 | −2.21 | 56.33 | 20.15 | 176.22 | −0.35 | −2.20 | 10.31 | 62.04 | 4 | 3 |
| 20 | −73460.18 | −4116.22 | −55.72 | 2.21 | −8.77 | −0.51 | 311.49 | 260.89 | −7.25 | 0.68 | 83.38 | 30.25 | 259.35 | −0.30 | 1.37 | 9.14 | 41.49 | 2 | 3 |
Regression models for the correlation between values of biological activity (pK , pD 2, pA 2) and chromatographic data and molecular descriptors.
| Equation no. | p |
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
| (1)a | a + bC-S2 − cS1/C + dS3/C − eS2/ | 0.83 | 0.68 | 7.4815 | 0.6687 | 0.0019 | 19 |
| (2)b | a + bC-S5 − cS5/C − dC-S4 + eC-S1 | 0.73 | 0.53 | 4.0085 | 0.8087 | 0.0226 | 19 |
| (3) | a + b | 0.83 | 0.69 | 11.0470 | 0.6387 | 0.0004 | 19 |
| (4)a | a − bHD + c log | 0.78 | 0.60 | 5.3183 | 0.7462 | 0.0081 | 19 |
| (5)b | a − bHD + cC-S5 + dlog | 0.90 | 0.80 | 14.6095 | 0.5272 | 0.0001 | 19 |
|
| |||||||
| p | |||||||
|
| |||||||
| (6)a | a − bC-S4 + cC-S5 | 0.92 | 0.84 | 26.6280 | 0.3654 | 0.0001 | 13 |
| (7)b | a − bS5/C − cC-S4 | 0.68 | 0.46 | 4.2261 | 0.6766 | 0.0467 | 13 |
| (8) | a + b log | 0.77 | 0.57 | 6.7003 | 0.6008 | 0.0142 | 13 |
| (9)a | a − bC-S4 + cC-S5 – d | 0.93 | 0.86 | 19.2116 | 0.3560 | 0.0003 | 13 |
| (10)b | a + blog | 0.77 | 0.60 | 7.4952 | 0.5814 | 0.0103 | 13 |
|
| |||||||
| p | |||||||
|
| |||||||
| (11)a | a − bC-S7 + cS1 + dS4/C | 0.61 | 0.37 | 2.3231 | 1.0017 | 0.1267 | 16 |
| (12)b | a − bC-S6 + cC-S3 + dS1/C | 0.83 | 0.69 | 8.8524 | 0.7026 | 0.0022 | 16 |
| (13) | a + b Δ | 0.83 | 0.69 | 8.8893 | 0.7073 | 0.0022 | 16 |
| (14)a | a − b | 0.83 | 0.68 | 8.6594 | 0.7080 | 0.0025 | 16 |
| (15)b | a + bC-S6 + cΔ | 0.88 | 0.78 | 14.0194 | 0.5934 | 0.0003 | 16 |
aChromatographic parameters from the experiment in RP2 TLC DS system. bChromatographic parameters from the experiment in RP2 TLC DS system. cThe correlation coefficient. dThe coefficient of determination. eThe variance ratio F. fThe standard error of estimate. gThe significance level of the equation. hThe number of compounds used to derive the regression equation.
QSAR statistics of significant equations.
| Equation no. | Equation |
|
|
|
|
|
|
| SDEP | PRESS |
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (5) | p | 0.90 | 0.80 | 0.75 | 14.6095 | 0.5272 | 0.0001 | 0.70 | 0.5883 | 6.3052 | 0.5761 | 0.63 | 19 |
|
| |||||||||||||
| (6) | p | 0.92 | 0.84 | 0.81 | 26.6280 | 0.3654 | 0.0001 | 0.73 | 0.4522 | 2.3390 | 0.4242 | 0.70 | 13 |
|
| |||||||||||||
| (15) | p | 0.88 | 0.78 | 0.72 | 14.0194 | 0.5934 | 0.0003 | 0.57 | 0.7633 | 8.6092 | 0.7335 | 0.55 | 16 |
R 2 adj: the adjusted squared correlation coefficient; Q LOO 2 and Q LNO 2: the squared correlation coefficients of the LOO and LNO validation procedures, respectively; SDEP: the standard deviation of error of prediction; PRESS: the predicted residual sum of squares; S PRESS: the standard deviation based on PRESS.
Correlation matrix of the biological activity (pK i, pA 2 and pD 2) and molecular descriptors used in (A) ((5) and (15)) and (B) (6).
| C-S4 | C-S5 | C-S6 | Δ | log | HD | p | p | |
|
| ||||||||
| (A) | ||||||||
| C-S4 | 1.00 | |||||||
| C-S5 | −0.10 | 1.00 | ||||||
| C-S6 | 0.62 | 0.08 | 1.00 | |||||
| Δ | 0.10 | 0.22 | 0.34 | 1.00 | ||||
| log | 0.21 | −0.20 | 0.02 | −0.35 | 1.00 | |||
| HD | −0.12 | −0.07 | −0.46 | −0.54 | 0.16 | 1.00 | ||
| p | 0.48 | −0.10 | 0.62 | 0.60 | 0.23 | −0.29 | 1.00 | |
| p | −0.33 | 0.57 | 0.02 | 0.11 | 0.22 | −0.39 | −0.11 | 1.00 |
|
| ||||||||
| C-S4 | C-S5 | p | ||||||
|
| ||||||||
| (B) | ||||||||
| C-S4 | 1.00 | |||||||
| C-S5 | 0.48 | 1.00 | ||||||
| p | −0.81 | −0.03 | 1.00 | |||||
Observed and predicted values of activity for Equations (5), (6), and (15).
| Compound | p | p | p | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Observed | Predicted | Residual | Observed | Predicted | Residual | Observed | Predicted | Residual | |
| 1 | — | — | — | 7.97 | 7.26 | 0.71 | 5.10 | 4.78 | 0.32 |
| 2 | 7.60 | 7.30 | 0.30 | 7.99 | 8.04 | −0.05 | 7.30 | 7.19 | 0.11 |
| 3 | 7.00 | 7.39 | −0.39 | 7.88 | 8.11 | −0.23 | 6.90 | 6.29 | 0.61 |
| 4 | 7.90 | 8.02 | −0.12 | 8.04 | 7.85 | 0.19 | 5.70 | 6.64 | −0.94 |
| 5 | 6.00 | 6.93 | −0.93 | — | — | — | 7.50 | 7.53 | −0.03 |
| 6 | 9.90 | 8.46 | 1.44 | 8.16 | 8.41 | −0.25 | 6.69 | 7.43 | −0.74 |
| 7 | 8.10 | 8.29 | −0.19 | 8.10 | 7.83 | 0.27 | 7.20 | 7.34 | −0.14 |
| 8 | 8.40 | 8.62 | −0.22 | — | — | — | 6.60 | 6.23 | 0.37 |
| 9 | 8.22 | 8.55 | −0.33 | — | — | — | 8.73 | 8.45 | 0.28 |
| 10 | 7.40 | 7.39 | 0.01 | — | — | — | 8.79 | 7.94 | 0.85 |
| 11 | 9.70 | 9.90 | −0.20 | 8.09 | 7.62 | 0.47 | 7.50 | 8.12 | −0.62 |
| 12 | 7.40 | 7.31 | 0.09 | — | — | — | 9.20 | 8.66 | 0.54 |
| 13 | 8.40 | 8.10 | 0.30 | 6.88 | 7.41 | −0.53 | 7.99 | 8.10 | −0.11 |
| 14 | 7.70 | 7.61 | 0.09 | 7.70 | 7.85 | −0.15 | 6.35 | 6.93 | −0.58 |
| 15 | 6.60 | 6.69 | −0.09 | 5.80 | 6.05 | −0.25 | — | — | — |
| 16 | 6.40 | 6.57 | −0.17 | 6.30 | 6.31 | −0.01 | — | — | — |
| 17 | 6.60 | 6.45 | 0.15 | 6.20 | 6.21 | −0.01 | — | — | — |
| 18 | 7.40 | 7.45 | −0.05 | 7.60 | 7.77 | −0.17 | 7.30 | 6.86 | 0.44 |
| 19 | 6.40 | 5.89 | 0.51 | — | — | — | — | — | — |
| 20 | 7.50 | 7.70 | −0.20 | — | — | — | 6.08 | 6.43 | −0.35 |
Figure 1Observed versus predicted values of serotoninergic binding affinity pK i according to (5).
Figure 2Observed versus predicted values of agonistic activity pD 2 according to (6).
Figure 3Observed versus predicted values of antagonistic activity pA 2 according to (15).